Home Page Headlines

International patient admissions for private medical treatment and diagnosis in the UK have soared by nearly 800% since 2016, data from from the Private Healthcare Information Network (PHIN) indicates. It shows there...

Holloway Friendly has made eight underwriting promises to advisers and their clients including attempting to match better terms from other insurers and for advisers to challenge it if they disagree with a...

BrokerIQ Solutions has launched the full version its Your Advisor Here (YAH) customer relationship management (CRM) software. It is an extension of the application and offers advisers their own customised app linked...

Legal & General has seen an 11% increase in UK protection sales in the first half of 2024, driven by its group risk business, compared to the same period last year. However,...

HSBC Life UK has promoted Richard Waters to head of protection distribution. Waters (pictured) has spent more than 30 years at HSBC having started as an insurance broker at the bank in...

Iress has added ex-smoker questions for its term and critical illness comparison service on The Exchange sourcing platform. The feature, supported at launch by Aviva and Royal London, aims to promote greater...

Lockton India has appointed Amit Agrawal as chief operating officer and chief financial officer. Agrawal joins Lockton from Aon India where he was chief financial officer. He has led on strategic initiatives,...

The Chartered Insurance Institute (CII) should create talent attraction ambassadors (TAA) to encourage young talent into the sector. The recommendation features among a series of calls to the CII by authors of...

Former Advo Group owner Colin Boxall speaks to Health & Protection about why the intense market competition meant now was the right time to sell up and how his departure from health...

Reframe Cancer has joined group risk industry body Grid. Reframe Cancer is a cancer navigation and support specialist that provides workplace care for employers and employees affected by cancer. As well as...